PA SB421 | 2009-2010 | Regular Session
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 20 2009 - 25% progression, died in committee
Action: 2009-02-20 - Referred to PUBLIC HEALTH AND WELFARE
Pending: Senate Public Health & Welfare Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on February 20 2009 - 25% progression, died in committee
Action: 2009-02-20 - Referred to PUBLIC HEALTH AND WELFARE
Pending: Senate Public Health & Welfare Committee
Text: Latest bill text (Introduced) [HTML]
Summary
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, providing for the definitions of "clinical trial" and "pharmaceutical drug" and for drug manufacturer clinical trials reporting; and further providing for prohibited acts and penalties.
Title
Providing for the definitions of "clinical trial" and "pharmaceutical drug" and for drug manufacturer clinical trials reporting; and further providing for prohibited acts and penalties.
Sponsors
Sen. Lisa Boscola [D] | Sen. Patrick Browne [R] | Sen. Jay Costa [D] | Sen. Edwin Erickson [R] |
Sen. Jim Ferlo [D] | Sen. Michael O'Pake [D] | Sen. John Rafferty [R] | Sen. Patricia Vance [R] |
Sen. Leanna Washington [D] |
History
Date | Chamber | Action |
---|---|---|
2009-02-20 | Referred to PUBLIC HEALTH AND WELFARE |